INDIA IPO
  • Home
  • About
    • About us
    • Our CSR
  • Services

    IPO

    • Initial Public Offering (IPO)
    • SME IPO Consultation
    • Mainline IPO Consultation
    • Follow-On Public Offer (FPO)
    • Pre-IPO Funding Consultants

    Capital Raising

    • Social Stock Exchange
    • Private Placement
    • Project Funding
    • REIT
    • SM REIT
    • Rights Issue Advisory
    • InvIT Rights Issue
    • InvIT Public Issue
    • InvIT Private Issue
    • Debt Syndication
    • Securitised Debt Instruments
    • Public Municipal Debt
    • Private Municipal Debt

    Finance Advisory

    • Business Valuation
    • Corporate Finance
    • Financial Modelling
    • Project Finance
  • Investors
  • Merchant Bankers

    SME

    • List of SME Merchant Bankers

    MAINBOARD

    • List of Mainboard Merchant Bankers
  • Resources

    Reports

    • Daily Reporter
    • IPO Calendar
    • Upcoming IPO Calendar
    • Mainline IPO Report
    • SME IPO Report
    • SME IPOs by Sector
    • Mainboard IPOs by Sector

    IPO Knowledge

    • IPO World Magazine
    • IPO Process
    • Pre-IPO Process Guidance
    • IPO Blogs
    • Sector Wise IPO List In India
    • List of IPO Registrar

    Notifications / Circulars

    • SEBI ICDR Amendment Regulations 10.03.2025
    • SEBI SME IPO ICDR Amendments report 10.03.25
    • ICDR
    • BSE SME Eligibility Criteria
    • NSE Emerge Eligibility Criteria
  • News/Updates
    • Markets & Money Update
    • IPO & Market Snaps
  • Contact Us
  • Check IPO Feasibility
Check IPO Feasibility
INDIA IPO
INDIA IPO

Contact Info:

  • +91-96506-37280
  • +011-47008280
  • info@indiaipo.in
  • 808, 8thFloor D-Mall, Netaji Subhash Place, Pitampura, Delhi-110034.
shape
  1. Home
  2. News
  3. Neogen Chemicals Schedules Board Meeting on March 7, 2026 for Preferential Issue of Equity Shares
ipo services in India
India IPO
  • 04 Mar 2026
  • X
 Neogen Chemicals Schedules Board Meeting on March 7, 2026 for Preferential Issue of Equity Shares

Neogen Chemicals Limited has scheduled a board meeting for March 7, 2026, to consider and approve a preferential issue of equity shares for fund raising purposes. The proposal will be structured in one or more tranches, with pricing and terms determined according to SEBI ICDR Regulations 2018 and Companies Act, 2013. The initiative requires shareholder approval through general meeting or postal ballot, along with necessary regulatory permissions. The company has implemented trading window restrictions for designated persons effective immediately until 48 hours post-meeting conclusion, ensuring compliance with insider trading regulations.

Neogen Chemicals Schedules Board Meeting on March 7, 2026 for Preferential Issue of Equity Shares

Neogen Chemicals Limited has informed stock exchanges about an upcoming board meeting scheduled for March 7, 2026, to consider a significant corporate action involving fund raising through equity shares. Board Meeting Details The company's Board of Directors will convene on Saturday, March 7, 2026, to evaluate and approve a proposal for raising funds through a preferential issue of equity shares. The meeting agenda includes comprehensive deliberation on the fund raising mechanism and associated terms. Meeting Parameter: Details Date: March 7, 2026 Purpose: Preferential issue of equity shares Structure: One or more tranches Regulatory Framework: SEBI ICDR Regulations 2018 Fund Raising Proposal Structure The proposed fund raising will be executed through a preferential issue of equity shares, with the board having discretion over the final structure and terms. The pricing mechanism will follow SEBI regulations, specifically Chapter V of the Securities and Exchange Board of India (Issue of Capital and Disclosure Requirement) Regulations, 2018. Key aspects of the proposal include: Issuance in one or more tranches as deemed appropriate Pricing determination pursuant to SEBI ICDR Regulations Compliance with Companies Act, 2013 provisions Board committee discretion on terms and conditions Regulatory Compliance and Approvals The fund raising initiative requires multiple layers of approval to proceed. The company has outlined a comprehensive approval framework that ensures regulatory compliance at every stage. Approval Type: Requirement Shareholder Approval: General meeting or postal ballot Regulatory Compliance: SEBI ICDR Regulations 2018 Statutory Compliance: Companies Act, 2013 Additional Approvals: Other regulatory permissions as required Trading Window Restrictions In compliance with insider trading regulations, Neogen Chemicals has implemented immediate trading restrictions. The trading window for company shares will remain closed for all designated persons and their immediate relatives, connected persons, and legitimate insiders. The restriction period extends from immediate effect until 48 hours after the conclusion of the March 7, 2026 board meeting. This measure ensures compliance with SEBI (Prohibition of Insider Trading) Regulations, 2015, and the company's internal Code of Conduct for trading oversight. Communication and Disclosure The company has fulfilled its disclosure obligations by notifying both major stock exchanges about the upcoming board meeting. The intimation was sent to BSE Limited and National Stock Exchange of India Limited on March 4, 2026, in accordance with Regulation 29 of SEBI Listing Regulations. Additionally, the company has made the information publicly available on its official website under the announcements section, specifically within the issue of securities tab, ensuring transparent communication with all stakeholders. Neogen chemicals has received Rs 60 crore as the third on-account insurance payment for the fire incident that occurred at its Dahej facility in March 2025. The payment was released based on recommendations from surveyors in their interim report, bringing the company's total insurance claims received to Rs 140 crore. Insurance Claim Settlement Details The insurance payment relates to the fire incident that took place at the Multi-Purpose Plant (MPP3) facility, warehouse, and tank farms located at Dahej SEZ on March 5, 2025, at around 12:30 a.m. IST. The company disclosed that further settlement will be determined in various stages following the completion of assessment for loss of property, plant and equipment including other assets at the Dahej SEZ Plant. Claim Details: Amount (Rs Crore) Third On-Account Payment: 60.00 Total Claims Received Till Date: 140.00 Total Recognized Loss (Standalone): 348.16 Total Recognized Loss (Consolidated): 362.90 Insurance Claim Receivable (Standalone): 334.60 Insurance Claim Receivable (Consolidated): 348.82 Financial Impact Assessment The company has recognized a total loss of Rs 348.16 crore on a standalone basis, which increases to Rs 362.90 crore on a consolidated basis. This loss accounts for damage to property, plant and equipment, inventory, and estimated cost of incidental charges. Neogen Chemicals has recognized an insurance claim receivable of Rs 334.60 crore on a standalone basis after adjusting applicable deductibility. The net impact after considering insurance claims stands at Rs 13.56 crore on a standalone basis and Rs 14.08 crore on a consolidated basis. Additionally, the company has received Rs 3.48 crore from the sale of salvaged scrap materials. Production Status and Recovery Plans Production and operations at the affected Multi-Purpose Plant (MPP3) facility, warehouse, and tank farms remain temporarily suspended. However, the company has initiated construction of a replacement plant, with commissioning scheduled for Q1 FY27. Recovery Measures: Status Replacement Plant Construction: Progressing rapidly Commissioning Timeline: Q1 FY27 Production Shift: Critical products moved to other sites Customer Approvals: Obtained for alternative production sites To minimize business disruption, Neogen Chemicals has shifted production of critical select specialty products to other sites based on customer approvals. The company is also implementing planned expansion at its Patancheru Plant to help minimize the impact on earnings going forward. Regulatory Compliance The disclosure was made under Regulation 30 and Regulation 51 of the SEBI Listing Obligations and Disclosure Requirements Regulations, 2015. This update follows previous disclosures made on March 5, 2025, March 7, 2025, April 23, 2025, June 27, 2025, and July 16, 2025 regarding the fire incident. The company continues to assess the full extent of losses including loss of profit due to business interruption and reinstatement value of assets. We’re building Scanx - to help you express your trading & investing idea, to help you analyse the markets better. Stock Markets are the true indicator of the growth of any country's economy. We are bullish on India, we are bullish on India's prospects to be one of largest economies of the world. We believe that Stock Markets provide an unique opportunity for all Indians to participate in the growth story of India. We are enabling the same for Indians. As financial services are becoming more accessible, there is now a large set of Indians today who are financially aware and literate. They value time and seek high quality products & services. Most screening, trading, investing platforms available today are more or less similar to each other, and they have not evolved with time. While both traders & investors have gotten smart about how they make money and build wealth, as users they have continued to use the same products, features, and platforms that were available for years with little or no innovation. We plan to change that - a technology-led platform built for super traders and long term investors.

Recent News

Moneyview files draft papers with Sebi for IPO; plans Rs 1,500 crore fresh issue
moneyview-files-draft-papers-with-sebi-for-ipo-plans-rs-1500...
04 Mar 2026
Mufin Green Finance Completes ₹324 Crore Preferential Allotment of Equity Shares and Warrants
mufin-green-finance-completes-rs324-crore-preferential-allot...
04 Mar 2026
Moneyview's IPO: Fintech Giant Prepares for Market Splash
moneyviews-ipo-fintech-giant-prepares-for-market-splash
04 Mar 2026
Advait Energy Transitions Allots 5,630 Equity Shares Through Warrant Conversion
advait-energy-transitions-allots-5630-equity-shares-through-...
04 Mar 2026
PhonePe eyes up to $10.5 billion valuation in India IPO, plans about $1 billion
phonepe-eyes-up-to-105-billion-valuation-in-india-ipo-plans-...
04 Mar 2026
HDFC Mutual Fund sells shares worth Rs 358 crore in Sundram Fasteners
hdfc-mutual-fund-sells-shares-worth-rs-358-crore-in-sundram-...
04 Mar 2026
Moneyview Limited files DRHP for ₹1,500 crore IPO
moneyview-limited-files-drhp-for-rs1500-crore-ipo
04 Mar 2026
Tamil Nadu eyes global shipyards with equity, leasing push under Shipbuilding Policy
tamil-nadu-eyes-global-shipyards-with-equity-leasing-push-un...
04 Mar 2026
Cyient Limited Allots 3623 Equity Shares Under Stock Option Plans ASOP 2015 and ARSUS 2020
cyient-limited-allots-3623-equity-shares-under-stock-option-...
04 Mar 2026
Sedemac Mechatronics IPO receives 27 pc subscription on Day 1
sedemac-mechatronics-ipo-receives-27-pc-subscription-on-day-...
04 Mar 2026
pre ipo advisory services in India
  • GST No: 07AAHCB7068H2ZF

India IPO is a leading Indian business services platform that helps firms and companies to launch their initial public offerings (IPOs) in order to raise essential capital for growth and expansion while adding value & fueling the nation’s immense potential and future opportunities.

Follow us:

Facebook Twitter LinkedIn Instagram YouTube

Quick Links

  • Home
  • Blogs
  • Consultant
  • Youtube Videos
  • News
  • Contact Us
  • Career

Contact Information:

  • Corporate Office: 808, 8th Floor, D-Mall, Netaji Subhash Place, Pitampura, Delhi-110034
  • Regional Office: Office No. 601, Shagun Insignia, Ulwe, Sector-19, Navi Mumbai- 410206
  • Email: info@indiaipo.in
  • Mobile: +91-74283-37280, +91-96509-82781
  • Disclaimer  |
  • Privacy & Policy  |
  • Terms & Conditions  

Copyright © All rights reserved by - Bmarkt Tecamat Private Limited